Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT07030257 · RECRUITING
Trial details
- NCT number
- NCT07030257
- Sponsor
- Tasca Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-27
- Primary completion
- 2028-08-15
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.